Return On Equity of Monopar Therapeutics from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Monopar Therapeutics quarterly and annual Return On Equity in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • Monopar Therapeutics Return On Equity for the quarter ending 30 Sep 2025 was -26%, a 76% increase year-over-year.
  • Monopar Therapeutics annual Return On Equity for 2024 was -85%, a 27% increase from 2023.
  • Monopar Therapeutics annual Return On Equity for 2023 was -116%, a 49% decline from 2022.
  • Monopar Therapeutics annual Return On Equity for 2022 was -78%, a 89% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Monopar Therapeutics Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -26% +82% +76% 01 Jul 2025 30 Sep 2025
Q2 2025 -42% +69% +62% 01 Apr 2025 30 Jun 2025
Q1 2025 -55% +55% +50% 01 Jan 2025 31 Mar 2025
Q4 2024 -85% +31% +27% 01 Oct 2024 31 Dec 2024
Q3 2024 -107% +6% +5.2% 01 Jul 2024 30 Sep 2024
Q2 2024 -111% -10% -9.6% 01 Apr 2024 30 Jun 2024
Q1 2024 -111% -20% -21% 01 Jan 2024 31 Mar 2024
Q4 2023 -116% -38% -49% 01 Oct 2023 31 Dec 2023
Q3 2023 -113% -48% -73% 01 Jul 2023 30 Sep 2023
Q2 2023 -101% -43% -75% 01 Apr 2023 30 Jun 2023
Q1 2023 -91% -43% -90% 01 Jan 2023 31 Mar 2023
Q4 2022 -78% -37% -89% 01 Oct 2022 31 Dec 2022
Q3 2022 -65% -25% -63% 01 Jul 2022 30 Sep 2022
Q2 2022 -58% -20% -53% 01 Apr 2022 30 Jun 2022
Q1 2022 -48% -8% -19% 01 Jan 2022 31 Mar 2022
Q4 2021 -41% +3% +6% 01 Oct 2021 31 Dec 2021
Q3 2021 -40% -1% -1.7% 01 Jul 2021 30 Sep 2021
Q2 2021 -38% +5% +12% 01 Apr 2021 30 Jun 2021
Q1 2021 -40% +5% +11% 01 Jan 2021 31 Mar 2021
Q4 2020 -44% +16% +27% 01 Oct 2020 31 Dec 2020
Q3 2020 -39% +30% +43% 01 Jul 2020 30 Sep 2020
Q2 2020 -43% +17% +29% 01 Apr 2020 30 Jun 2020
Q1 2020 -45% +5% +9.3% 01 Jan 2020 31 Mar 2020
Q4 2019 -60% -21% -55% 01 Oct 2019 31 Dec 2019
Q3 2019 -70% -36% -107% 01 Jul 2019 30 Sep 2019
Q2 2019 -60% 01 Apr 2019 30 Jun 2019
Q1 2019 -50% 01 Jan 2019 31 Mar 2019
Q4 2018 -39% 01 Oct 2018 31 Dec 2018
Q3 2018 -34% 01 Jul 2018 30 Sep 2018

Monopar Therapeutics Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -85% +31% +27% 01 Jan 2024 31 Dec 2024
2023 -116% -38% -49% 01 Jan 2023 31 Dec 2023
2022 -78% -37% -89% 01 Jan 2022 31 Dec 2022
2021 -41% +3% +6% 01 Jan 2021 31 Dec 2021
2020 -44% +16% +27% 01 Jan 2020 31 Dec 2020
2019 -60% -19% -46% 01 Jan 2019 31 Dec 2019
2018 -41% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.